Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fecal Microbial Transplantation in Adults With Moderate-to-Severe Atopic Dermatitis
NCT04283968Phase 3Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Oct 2020
- Primary completion
- Jun 2023
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of allogeneic fecal microbiota in atopic dermatitis (AD), sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
allogeneic fecal microbiota
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT04283968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04283968.